Next Article in Journal
Palbociclib Capsule: A Bioequivalence Study in Healthy Subjects Under Fed Conditions to Compare Two Formulations
Previous Article in Journal
Fibroblast-Targeted Nanodelivery Systems: Mechanisms of Collagen Remodeling Regulation and Novel Strategies for Scar Repair
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 18
Issue 2
10.3390/pharmaceutics18020174
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Pharmaceutics 2022, 14(5), 969.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: MacCuaig et al. Toxicity Assessment of Mesoporous Silica Nanoparticles upon Intravenous Injection in Mice: Implications for Drug Delivery. Pharmaceutics 2022, 14, 969

by
William M. MacCuaig
1,2,
Abhilash Samykutty
1,
Jeremy Foote
3,
Wenyi Luo
1,4,
Alexander Filatenkov
1,4,
Min Li
1,5,
Courtney Houchen
1,5,
William E. Grizzle
6 and
Lacey R. McNally
1,7,*
1
Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK 73104, USA
2
Department of Biomedical Engineering, University of Oklahoma, Norman, OK 73109, USA
3
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
4
Department of Pathology, Oklahoma Health Science Center, Oklahoma City, OK 73104, USA
5
Department of Medicine, Oklahoma Health Science Center, Oklahoma City, OK 73049, USA
6
Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
7
Department of Surgery, Oklahoma Health Science Center, Oklahoma City, OK 73104, USA
*
Author to whom correspondence should be addressed.
Pharmaceutics 2026, 18(2), 174; https://doi.org/10.3390/pharmaceutics18020174
Submission received: 11 December 2025 / Accepted: 15 December 2025 / Published: 29 January 2026
Browse Figure
Versions Notes
Error in Figure
In the original publication [1], there was a mistake in Figure 4 as published. The authors wish to correct the inadvertently duplicated histology image within the panel. This occurred as a version control error over the course of the revision process. The corrected Figure 4 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. MacCuaig, W.M.; Samykutty, A.; Foote, J.; Luo, W.; Filatenkov, A.; Li, M.; Houchen, C.; Grizzle, W.E.; McNally, L.R. Toxicity Assessment of Mesoporous Silica Nanoparticles upon Intravenous Injection in Mice: Implications for Drug Delivery. Pharmaceutics 2022, 14, 969. [Google Scholar] [CrossRef] [PubMed]
Pharmaceutics 18 00174 g004
Figure 4. H&E-stained organs from acute treatment groups (MSNs, C-MSNs, 2KPEG-MSNs, 35KPEG-MSNs). Images were acquired at 10× magnification.
Figure 4. H&E-stained organs from acute treatment groups (MSNs, C-MSNs, 2KPEG-MSNs, 35KPEG-MSNs). Images were acquired at 10× magnification.
Pharmaceutics 18 00174 g004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

MacCuaig, W.M.; Samykutty, A.; Foote, J.; Luo, W.; Filatenkov, A.; Li, M.; Houchen, C.; Grizzle, W.E.; McNally, L.R. Correction: MacCuaig et al. Toxicity Assessment of Mesoporous Silica Nanoparticles upon Intravenous Injection in Mice: Implications for Drug Delivery. Pharmaceutics 2022, 14, 969. Pharmaceutics 2026, 18, 174. https://doi.org/10.3390/pharmaceutics18020174

AMA Style

MacCuaig WM, Samykutty A, Foote J, Luo W, Filatenkov A, Li M, Houchen C, Grizzle WE, McNally LR. Correction: MacCuaig et al. Toxicity Assessment of Mesoporous Silica Nanoparticles upon Intravenous Injection in Mice: Implications for Drug Delivery. Pharmaceutics 2022, 14, 969. Pharmaceutics. 2026; 18(2):174. https://doi.org/10.3390/pharmaceutics18020174

Chicago/Turabian Style

MacCuaig, William M., Abhilash Samykutty, Jeremy Foote, Wenyi Luo, Alexander Filatenkov, Min Li, Courtney Houchen, William E. Grizzle, and Lacey R. McNally. 2026. "Correction: MacCuaig et al. Toxicity Assessment of Mesoporous Silica Nanoparticles upon Intravenous Injection in Mice: Implications for Drug Delivery. Pharmaceutics 2022, 14, 969" Pharmaceutics 18, no. 2: 174. https://doi.org/10.3390/pharmaceutics18020174

APA Style

MacCuaig, W. M., Samykutty, A., Foote, J., Luo, W., Filatenkov, A., Li, M., Houchen, C., Grizzle, W. E., & McNally, L. R. (2026). Correction: MacCuaig et al. Toxicity Assessment of Mesoporous Silica Nanoparticles upon Intravenous Injection in Mice: Implications for Drug Delivery. Pharmaceutics 2022, 14, 969. Pharmaceutics, 18(2), 174. https://doi.org/10.3390/pharmaceutics18020174

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop